Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2020-08, Vol.105 (8), p.e404-e407
Main Authors: Abboud, Ramzi, Chendamarai, Ezhilarasi, Rettig, Michael P, Trinkaus, Kathryn M, Riedell, Peter A, Abboud, Camille N, Ghobadi, Armin, Pusic, Iskra, Stockerl-Goldstein, Keith, Schroeder, Mark A, Vij, Ravi, Westervelt, Peter, DiPersio, John F, Uy, Geoffrey L
Format: Article
Language:English
Subjects:
Adult
Aged
Animals
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Cladribine - therapeutic use
Cytarabine - therapeutic use
Female
Filgrastim - therapeutic use
Humans
Hydrazines
Leukemia, Myeloid, Acute - drug therapy
Male
Mice, Inbred C57BL
Middle Aged
Online Only
Remission Induction
Treatment Outcome
Triazoles
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2019.236810